hexamethonium has been researched along with Arteriosclerosis in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KLEH, J | 1 |
| FAZEKAS, JF | 1 |
| WINDESHEIM, JH | 1 |
| ROTH, GM | 1 |
| GIFFORD, RW | 1 |
2 other studies available for hexamethonium and Arteriosclerosis
| Article | Year |
|---|---|
Cerebral hemodynamic studies on hypertensive-atherosclerotic subjects during hexamethonium therapy.
Topics: Arteriosclerosis; Brain; Cardiovascular System; Hemodynamics; Hexamethonium; Hypertension; Muscle Re | 1954 |
The use of hexamethonium in treatment of arteriosclerosis obliterans.
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cardiovascular Agents; Hexamethonium; Humans; Muscle | 1955 |